Park Avenue Securities LLC Raises Holdings in Itron, Inc. $ITRI

Park Avenue Securities LLC boosted its holdings in shares of Itron, Inc. (NASDAQ:ITRI) by 35.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,583 shares of the scientific and technical instruments company’s stock after buying an additional 1,188 shares during the quarter. Park Avenue Securities LLC’s holdings in Itron were worth $603,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of ITRI. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Itron by 129.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company’s stock valued at $76,713,000 after buying an additional 413,487 shares during the period. Amundi increased its holdings in Itron by 18.4% during the first quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company’s stock valued at $97,313,000 after buying an additional 144,361 shares during the period. GAMMA Investing LLC increased its holdings in Itron by 10,278.1% during the first quarter. GAMMA Investing LLC now owns 122,150 shares of the scientific and technical instruments company’s stock valued at $12,796,000 after buying an additional 120,973 shares during the period. MetLife Investment Management LLC increased its holdings in Itron by 347.2% during the first quarter. MetLife Investment Management LLC now owns 121,043 shares of the scientific and technical instruments company’s stock valued at $12,680,000 after buying an additional 93,977 shares during the period. Finally, Trexquant Investment LP increased its holdings in Itron by 122.5% during the first quarter. Trexquant Investment LP now owns 168,535 shares of the scientific and technical instruments company’s stock valued at $17,656,000 after buying an additional 92,773 shares during the period. 96.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ITRI has been the topic of several analyst reports. Guggenheim reaffirmed a “buy” rating and issued a $155.00 price target (up from $133.00) on shares of Itron in a report on Monday, July 14th. Roth Capital lifted their price target on shares of Itron from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. TD Cowen lifted their price target on shares of Itron from $139.00 to $145.00 and gave the stock a “buy” rating in a report on Friday, June 20th. Stephens set a $130.00 price target on shares of Itron in a report on Monday, August 4th. Finally, JPMorgan Chase & Co. raised shares of Itron from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $128.00 to $145.00 in a report on Thursday, July 31st. Nine research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $137.10.

Insider Activity at Itron

In related news, SVP Christopher E. Ware sold 351 shares of the business’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $43,983.81. Following the completion of the transaction, the senior vice president directly owned 19,117 shares in the company, valued at $2,395,551.27. The trade was a 1.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Justin K. Patrick sold 388 shares of the business’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $48,620.28. Following the transaction, the senior vice president owned 20,761 shares of the company’s stock, valued at $2,601,560.91. This represents a 1.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 3,037 shares of company stock valued at $380,566 over the last ninety days. Corporate insiders own 1.51% of the company’s stock.

Itron Trading Up 1.0%

NASDAQ:ITRI opened at $123.97 on Monday. Itron, Inc. has a 12 month low of $90.11 and a 12 month high of $140.04. The firm has a fifty day simple moving average of $125.16 and a 200-day simple moving average of $118.68. The company has a current ratio of 2.04, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $5.67 billion, a P/E ratio of 21.19, a PEG ratio of 0.68 and a beta of 1.46.

Itron (NASDAQ:ITRI) last posted its quarterly earnings data on Thursday, July 31st. The scientific and technical instruments company reported $1.62 EPS for the quarter, topping the consensus estimate of $1.33 by $0.29. Itron had a net margin of 11.05% and a return on equity of 19.69%. The business had revenue of $606.76 million during the quarter, compared to the consensus estimate of $610.36 million. During the same period in the previous year, the firm posted $1.21 earnings per share. The business’s revenue for the quarter was down .4% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, equities research analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current year.

Itron Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.